Veeva Systems provides cloud software built specifically for the global life-sciences industry, including CRM, content and quality management, clinical data and regulatory solutions. Its Vault platform and commercial applications are widely adopted by pharmaceutical and biotech companies that need industry-specific compliance and workflows. The subscription model centers on multi-product suites sold into R&D, quality, regulatory and commercial functions.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 759 | — | 228.2 | — |
| Q3 2025 | 789.1 | — | 200.3 | — |
| Q4 2025 | 811.2 | — | 236.2 | — |
| Q1 2026 | 836 | — | 244.2 | — |
| Q2 2026 | 883 | 16.3% | 260.9 | 14.3% |
| Q3 2026 | 928 | 17.6% | 273.4 | 36.5% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Entergy Corporation (ETR), Edwards Lifesciences Corporation (EW), United Microelectronics Corporation (UMC), Humana Inc. (HUM), Delta Air Lines, Inc. (DAL), Infosys Limited (INFY)